Maurin M and Raoult D |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8109928
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Waites KB et al. |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2973283
|
Wang G et al. |
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10049289
|
Yasuda H et al. |
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239580
|
Wakabayashi H et al. |
Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19451301
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Ferro BE et al. |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27458221
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Beeton ML et al. |
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19273669
|
Rimbara E et al. |
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18606842
|
Bolhuis MS et al. |
Clarithromycin significantly increases linezolid serum concentrations. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20837753
|
Nash KA et al. |
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19171799
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Fong IW et al. |
Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121899
|
Champney WS and Tober CL |
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348746
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Hotomi M et al. |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17698631
|
Berg HF et al. |
Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504839
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Rastogi N and Labrousse V |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828135
|
Luna-Herrera J et al. |
Antituberculosis activity of clarithromycin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593004
|
Ellis LC et al. |
Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593025
|
Truffot-Pernot C et al. |
Clarithromycin is inactive against Mycobacterium tuberculosis. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593032
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Mathis A et al. |
Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048933
|
Dai G et al. |
Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048962
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Collins LA et al. |
Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527783
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Shinkai M et al. |
Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16641444
|
Truffot-Pernot C et al. |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834015
|
Konstantinidis T et al. |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643338
|
Portaels F et al. |
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9687409
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Burucoa C et al. |
T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15673794
|
Woosley LN et al. |
CEM-101 activity against Gram-positive organisms. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20176910
|
Bermudez LE et al. |
EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17296742
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Fernandes PB et al. |
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2957954
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Bernut A et al. |
In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798271
|
Spyridaki I et al. |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19332671
|
Jones RN et al. |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20660671
|
Kosowska-Shick K et al. |
Comparative antipneumococcal activities of sulopenem and other drugs. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19307366
|
Donati M et al. |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20855744
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|